Background and Aims
Methods
Results
Conclusions
Abbreviations:
CI (confidence interval), EoE (eosinophilic esophagitis)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyReferences
- Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies.Aliment Pharmacol Therap. 2016; 43: 3-15
- Health care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States.Am J Gastroenterol. 2015; 110: 626-632
- Advances in clinical management of eosinophilic esophagitis.Gastroenterology. 2014; 147: 1238-1254
- Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients.Clin Gastroenterol Hepatol. 2008; 6: 598-600
- A phenotypic analysis shows eosinophilic esophagitis is a progressive fibrostenotic disease.Gastrointest Endosc. 2014; 79: 577-585
- Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis.Gastroenterol Clin North Am. 2014; 43: 297-316
- The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis.Gastrointest Endosc. 2016; 83: 1142-1148
- Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.Allergy. 2010; 65: 109-116
- Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.J Allerg Clin Immunol. 2011; 128: 1037-1046
- Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.Clin Gastroenterol Hepatol. 2011; 9: 400-409
- Esophageal dilation in eosinophilic esophagitis.Best Pract Res. 2015; 29: 815-828
- Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype.Am J Gastroenterol. 2016; 111: 206-213
- Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation.Am J Gastroenterol. 2010; 105: 1062-1070
- Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.Gastroenterology. 2013; 145: 1230-1236
- The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years.Gastrointest Endosc. 2014; 80: 592-598
- ACG Clinical Guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).Am J Gastroenterol. 2013; 108: 679-692
- Eosinophilic esophagitis: updated consensus recommendations for children and adults.J Allerg Clin Immunol. 2011; 128: 3-20
- Eosinophilic esophagitis dilation in the community—try it, you will like it—but start low and go slow.Am J Gastroenterol. 2016; 111 ([Editorial]): 214-216
- An audit of endoscopic complications in adult eosinophilic esophagitis.Clin Gastroenterol Hepatol. 2007; 5: 1149-1153
- Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.Gastroenterology. 2007; 133: 1342-1363
- Dilation in eosinophilic esophagitis: to do or not to do?.Gastrointest Endosc. 2010; 71: 713-714
- Endoscopy in eosinophilic esophagitis: “feline” esophagus and perforation risk.Clin Gastroenterol Hepatol. 2003; 1: 433-437
- Oesophageal dilation in adults with eosinophilic oesophagitis.Aliment Pharmacol Therap. 2011; 33 ([Review]): 748-757
- A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis.Dig Dis Sci. 2010; 55: 1512-1515
- Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis.Aliment Pharmacol Therap. 2013; 38: 713-720
- Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications.Gastrointest Endosc. 2010; 71: 706-712
- Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis.Gastrointest Endosc. 2011; 73: 15-21
- Dilation of pediatric eosinophilic esophagitis-adverse events and short term outcomes.J Pediatr Gastroenterol Nutr. 2017; 64: 701-706
- Savary dilation is safe and effective treatment for esophageal narrowing related to pediatric eosinophilic esophagitis.J Pediatr Gastroenterol Nutr. 2016; 63: 474-480
- Randomized controlled trial comparing esophageal dilation to no dilation among adults with esophageal eosinophilia and dysphagia.Dis Esoph. 2015; 29: 983-991
- The safety of a strict wire-guided dilation protocol for eosinophilic esophagitis.Eur J Gastroenterol Hepatol. 2014; 26: 699-703
- Esophageal dilations in eosinophilic esophagitis: a single center experience.World J Gastroenterol. 2014; 20: 9549-9555
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.J Clin Epidemiol. 2009; 62: e1-e34
- Distinguishing case series from cohort studies.Ann Intern Med. 2012; 156: 37-40
- Metaprop: a Stata command to perform meta-analysis of binomial data.Arch Public Health. 2014; 72: 39
- Severe dysphagia in children with eosinophilic esophagitis and esophageal stricture: an indication for balloon dilation?.J Pediatr Gastroenterol Nutr. 2010; 50: 516-520
- PTU-164 The clinical utility of the endoscopic functional luminal imaging probe in eosinophilic oesophagitis: a case series.Gut. 2012; 61: A252-A253
- Through-the-scope hydrostatic balloon dilation of strictures and rings is associated with low incidence of perforation in adults with eosinophilicesophagitis and dysphagia: the four-year experience of a single tertiary-care medical center.Gastroenterology. 2012; 142: S439
- intermittent dysphagia for solids associated with a multiringed esophagus: clinical features and response to dilatation.Dysphagia. 2007; 22: 55-62
- Hepatic portal venous gas: an unusual complication following upper endoscopy and dilation.ACG Case Rep J. 2014; 1: 128-130
- Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis.Endoscopy. 2006; 38: E43-E44
- The ringed esophagus: histological features of GERD.Am J Gastroenterol. 2001; 96: 984-989
- Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?.Gastrointest Endosc. 2003; 57: 407-412
- Natural history and management of refractory benign esophageal strictures.Gastrointest Endosc. 2016; 84: 222-228
- Dilation of refractory benign esophageal strictures.Gastrointest Endosc. 2009; 70: 1000-1012
- Non-adherence to the rule of 3 does not increase the risk of adverse events in esophageal dilation.Gastrointest Endosc. 2016; 85: 332-337
- Perforation during esophageal dilatation: a 10-year experience.J Gastrointest Liver Dis. 2013; 22: 385-389
- Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature.Dis Esoph. 2007; 20: 311-319
- Management guidelines of eosinophilic esophagitis in childhood.J Pediatr Gastroenterol Nutr. 2014; 58: 107-118
- Esophageal dilation: simple and effective treatment for adults with eosinophilic esophagitis and esophageal rings and narrowing.Dis Esoph. 2010; 23: 377-385
- Clinical and endoscopic features of eosinophilic esophagitis in adults.Gastrointest Endosc. 2003; 58: 516-522
- Eosinophilic esophagitis in adults: An emerging problem with unique esophageal features.Gastrointest Endosc. 2004; 59: 355-361
- Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years.Gastroenterology. 2003; 125: 1660-1669
- Esophageal eosinophilia with dysphagia.Dig Dis Sci. 1993; 38: 109-116
- Corrugated ringed esophagus.Am J Gastroenterol. 1993; 88: 1461
- Multiple rings of the esophagus associated with gastroesophageal reflux.Am J Gastroenterol. 1996; 91 ([case report]): 574-576
- Efficacy of intralesional triamcinolone injections for benign refractory oesophageal strictures at Counties Manukau Health, New Zealand.N Z Med J. 2015; 128: 44-50
- Dilation of an esophageal stricture using a balloon with integrated impedance planimetry imaging.Dis Esoph. 2014; 27: 3A-168A
- Safety of dilation in adults with eosinophilic esophagitis.Dis Esoph. 2013; 26: 241-245
- Eosinophilic esophagitis: clinical features, endoscopic findings and response to treatment.Can J Gastroenterol. 2010; 24: 547-551
- Eosinophilic esophagitis: dilate or medicate?.Gastroenterology. 2009; 136: A281-A282
- Dilation treatment in eosinophilic esophagitis.Can J Gastroenterol. 2009; 23
- Ring(s)-related esophageal meat bolus impaction: biopsy first, dilate later.Dis Esoph. 2009; 22: E14-E16
- Long-lasting effect of endoscopic dilatation of an esophageal stenosis due to eosinophilic esophagitis.J Gastrointest Liver Dis. 2006; 15: 167-170
- Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases.Dig Liver Dis. 2005; 37: 129-134
- Eosinophilic esophagitis: the Ochsner Clinic experience.Am J Gastroenterol. 2005; 100: S41
- The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis.Gastrointest Endosc. 2002; 55: 99-106
- Idiopathic eosinophilic esophagitis with stricture formation in a patient with long-standing eosinophilic gastroenteritis.Gastrointest Endosc. 1997; 46: 557-560
- Radiographic abnormalities in eosinophilic esophagitis.Gastrointest Radiol. 1985; 10: 321-324
Article info
Publication history
Footnotes
DISCLOSURE: The following authors received research support for this study from the National Institutes of Health: M. Dougherty, T. M. Runge, S. Eluri (award T32 DK007634); E. S. Dellon (award R01 DK101856). In addition, the following author disclosed financial relationships relevant to this publication: E. S. Dellon: Consultant for Adare, Banner, Receptos, Regeneron, Roche, and Shire; research funding recipient for Meritage, Miraca, Nutricia, Receptos, Regeneron, and Shire; educational grant recipient from Banner. All other authors disclosed no financial relationships relevant to this publication.
See CME section; p. 731.
If you would like to chat with an author of this article, you may contact Dr Dellon at [email protected]